Cargando…
Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer
The inhibitor of DNA-binding (Id) proteins, Id1–4 are negative regulators of basic helix-loop-helix (bHLH) transcription factors. As key regulators of cell cycle and differentiation, expression of Id proteins are increasingly observed in many cancers and associated with aggressiveness of the disease...
Autores principales: | Sharma, Pankaj, Chinaranagari, Swathi, Patel, Divya, Carey, Jason, Chaudhary, Jaideep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544455/ https://www.ncbi.nlm.nih.gov/pubmed/23342267 http://dx.doi.org/10.1002/cam4.16 |
Ejemplares similares
-
EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
por: Chinaranagari, Swathi, et al.
Publicado: (2014) -
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012) -
Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN
por: Sharma, Pankaj, et al.
Publicado: (2013) -
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
por: Carey, Jason PW, et al.
Publicado: (2009) -
Id4 dependent acetylation restores mutant-p53 transcriptional activity
por: Knowell, Ashley E, et al.
Publicado: (2013)